High fat diet is implicated in the elevated deoxycholic acid (DCA) in the intestine and correlated with increased colon cancer risk. However, the potential mechanisms of intestinal carcinogenesis by DCA remain unclarified. Here, we investigated the carcinogenic effects and mechanisms of DCA using the intestinal tumour cells and However, despite intensive researches over the years, the molecular mechanisms of intestinal cancer promotion by DCA remain to be further elucidated.
| INTRODUCTION
More than 95% of sporadic colorectal cancers (CRC) develop from adenomas over a number of years. 1, 2 Apart from hereditable components, environmental factors strongly determine the progression of intestinal neoplastic transformation, known as the adenoma-adenocarcinoma sequence. 2, 3 Several features include high fat diet (HFD), obesity and low levels of physical activity, are known risk factors for CRC, 4 and dietary fat intake could increase the secondary bile acids such as deoxycholic acid (DCA) in the intestine. 5 Previous studies including our data have shown that persistent and repeated exposure of intestinal epithelium to abnormally high concentrations of DCA appeared to induce DNA damage, genomic instability and alteration of the microbial community to promote CRC development. [6] [7] [8] However, despite intensive researches over the years, the molecular mechanisms of intestinal cancer promotion by DCA remain to be further elucidated.
Epidermal growth factor receptor (EGFR), which plays an important role in tumorigenesis, is overexpressed in many types of cancers, especially in CRC. 9, 10 EGFR tyrosine kinase activation leads to Dong, Liu and Dou equally contributed to this study.
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the activation of numerous of intracellular signals, which are critical to tumour progression, including cell growth, epithelial-mesenchymal transition (EMT), metastasis and angiogenesis. These changes are mediated by the downstream targets of EGFR, including extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt protein kinase. 11, 12 The proteolytic processing of EGFR soluble ligands, amphiregulin (AREG), heparin-binding (HB)-EGF or transforming growth factor (TGF)-a requires a disintegrin and metalloprotease (ADAM-17), which is also known as tumour necrosis factor-a converting enzyme (TACE). As a member of the ADAM family of metalloproteases, ADAM-17 involves in cell adhesion, migration, cellular signalling and proteolysis, 13 recently emerging as a potential therapeutic target in several tumour types. 14, 15 Our previous studies have already showed that DCA enhanced the multiplicity of intestinal tumours and accelerated intestinal adenoma-adenocarcinoma sequence in Apc min/+ mice. 7, 16 And recent research provided evidence that DCA induced EGFR/STAT3 signalling to promote gastrointestinal cancer progression. 15 In this study, we investigated whether DCA promoted intestinal carcinogenesis through activation of ADAM-17/EGFR signalling axis. Here, we provided the evidence that DCA up-regulated the release of AREG in accordance with EGFR/Akt activation, and ADAM-17 was required in the shedding AREG for activation of EGFR. These data defined a mechanism of DCA in promoting intestinal tumour development through ADAM-17-mediated AREG release, leading to activation of EGFR, and represented a potential target for the bile acidrelated intestinal cancer prevention and therapy.
| MATERIALS AND METHODS

| Cell culture and treatment
Young adult mouse colonic epithelium cell line (YAMC) cell line was generated using a mouse harbouring thermolabile mutation (tsA58) 
| Western blot analysis
The cells lysates were solubilized using RIPA buffer with protease inhibitors (Solarbio, Beijing, China) and homogenized. The protein concentrations were determined using Bicinchoninic acid protein assay (Solarbio, Beijing, China). Western blotting was performed on SDS-PAGE Electrophoresis System. The total cellular lysates were and was determined by comparing the density of the indicated band to the internal control band.
| Real-time PCR analysis
Total RNA was extracted using the RNeasy mini kit (Qiagen, Carlsbad, CA, USA), and cDNA reverse transcription was carried out using the TIANScript RT Kit (TIANGEN, Inc. Beijing, China) according to the manufacturer's instructions. The Oligonucleotide primers for target genes (GAPDH and AREG) were shown in Table S1 . The ΔΔCt method was used to calculate relative mRNA expression.
| Animal treatment and tissue processing
Apc min/+ mice on a C57BL/6J background were purchased from Animal Model Institution of Nanjing University, China. The mice were provided with either sterile water (n = 10) or 0.2% DCA in drinking water (n = 10) under specific pathogen free (SPF) conditions for 12 weeks as previously described. 7, 16 Signs of illness were monitored daily and body weight was recorded weekly. Mice were killed for intestinal tumour burden assessment and tissue collection as previously described. 16, 19 Tissue sections were prepared for haematoxylin and eosin (H&E) and immunohistochemical staining. Adenomas of distal small intestinal section were excised, immediately frozen in liquid nitrogen and then stored at À80°C until analysis for protein expression. Animal protocols were approved by the Institutional Animal Care and Use Committee at Tianjin Medical University, Tianjin, China. 
| Histopathology and immunohistochemistry
| TUNEL assay
Terminal deoxynucleotidyl transferase dUTP nick end labelling 
| Statistical analysis
Statistical analysis was performed on SPSS 22.0 (SPSS, Chicago, IL, USA). Data were presented as mean AE SD. Differences among groups were tested by one-way ANOVA for multiple comparison and t test for paired samples. P < .05 was considered significant.
| RESULTS
| DCA activated EGFR in intestinal tumour cells
The LGD, low-grade dysplasia. Scale bar: 50 lm. *P < .05, **P < .01, ***P < .001. n = 10/group
| DISCUSSION
The high fat diet has been linked with increased CRC risk and associated with high DCA production in the intestine. 5, 6, 20, 21 Despite intensive investigations in recent years, the molecular mechanisms of cancer promotion by DCA remain limited. Our present study had Apc mutation, an early stage of tumour development and the causative mutation in familial adenomatous polyposis, occurs in almost 80% sporadic colon adenomas and CRC in human. [22] [23] [24] Therefore, establishing the effects of DCA in a model with an Apc mutation is of great importance in mimicking human intestinal adenoma-adenocarcinoma sequence carcinogenesis. 7, 25 Researches had shown that the EGFR pathway was the most important target for CRC therapy. 41 Two FDA-approved monoclonal antibodies against EGFR have become clinically routine, but only a small part of patients had an effective result. 42, 43 Thus, the development of combinatory therapeutic target should be introduced into CRC therapy. 44 In this study, we found that DCA accelerated intestinal carcinogenesis through activation of ADAM-17/EGFR signalling axis. Further studies should be arranged to study the relationship between DCA and upstream components of ADAM-17/EGFR signalling axis, as specific nuclear receptors (FXR, PXR and vitamin D receptor) and G-protein-coupled receptors (TGR5, sphingosine-1 phosphate receptor 2 and muscarinic receptors). 45 In conclusion, we investigated the importance of ADAM-17/ EGFR signalling activation in the process of intestinal carcinogenesis by DCA treatment. This report also shows that DCA can stimulate release of AREG mediated by ADAM-17. Consequently, it may provide new insights that DCA promotes adenoma to adenocarcinoma progression. And ADAM-17/EGFR signalling axis will represent a potential target for the bile acid-related CRC therapy.
